1.
The title may not best reflect the focus of the paper. The findings as presented seem to better reflect a role for iASPP in maintaining normal epithelial homeostasis or inhibiting differentiation, rather than maintaining epithelial integrity (no defects in cell or tissue integrity are really shown).
2.
The section of the introduction dealing with skin differentiation (paragraph 1) needs more references to adequately describe the normal differentiation process and the contribution of cell adhesion. 3.
In figure 1 , the data clearly shows a role for iASPP expression in human keratinocytes (immunostaining on sections and matching protein level changes with calcium induced differentiation in culture). However, the staining in mouse and human tissues does not appear similar in all cases. It seems more diffuse and suprabasal in the mouse tissue, described as being in both the cytoplasm and in the nucleus. However, in the human skin, it appears only nuclear. In the human cultures, iASPP levels decrease with differentiation, whereas in the upper layers of the mouse tissue (E15.5, P1), expression seems to persist. Perhaps some clearer higher-powered images on the mouse sections would help. Is the antibody known to have similar specificity for mouse and human? The differences could be discussed more. 4.
From figure 2 and supp. figure 1, expression of the TAp63 isoforms appears to induce iASPP expression the most, but is not commented on. Does this reflect a response to TA inducing senescence or apoptosis, or an induction of differentiation? Are all isoforms of p63 (or at least the TA and N groups) lost with iASPP knockdown? 5.
In figure 3D , were any other miR¥s examined that were not induced by sh-iASPP? These could be included as negative controls. In figure 3E , was repression of p63 luciferase more potent in cells that do not express endogenous p63? Was this only repression of Np63? In Figure 3F , what was the efficiency of the antagomirs? Is it known how knockdown of iASPP induces miRNA expression? 6.
The emphasis on figure 4A and 4B is a little strong, taking into account the subsequently described cellular phenotypes. For such a dramatic loss of p63, PERP and desmosomal proteins, a significant decrease in cell number or attachment would be expected, considering previous studies (e.g. Ihrie et al, 2005; Carroll et al, 2006) . This could be discussed more. Does the cellular phenotype in figure 4C look similar to calcium-induced differentiation in these conditions? While in figure 5B , the premature differentiation is quite impressive. Could also be discussed more. 7.
In figure 4 or 5, would over-expression of iASPP affect the normal differentiation process? In the cells with expression of the anti-miR-720 or 574-3p antagomirs with calcium ( fig. 3g ), is the normal differentiation process in 3D cultures restored? 8.
Given iASPPs known function, was there any induction of apoptosis in the iASPP knockdown cells or 3D sections? 9.
It would be interesting to see the effect of iASPP knockdown on stem cells e.g. FACS analysis or culture of colonies on feeders.
Minor comments 1.
Throughout, molecular weight sizes should be included for western blots. 2.
Similarly, for western blots, the detected isoform of p63 should be labeled, e.g. figs. 1E, 2C, 2D, 2E, 2F, 3A, 3F. 3.
Similarly, for RT-PCR, p63 bands should be labeled with the correct isoform or DBD. 4.
Fig 1B needs labels on the y-axis e.g. relative cDNA levels. 5.
In results section 2, describing figure 2D , "up-regulation of iASPP" should be rephrased as "overexpression", as in the figure legend. 6.
The graphs in figure 3D have different axes 7.
In results section 3, "antagomirs" is spelled incorrectly. 8. Figure 4C needs labels. The "blurred edge" effect detracts from the clarity of the image. 9.
Supplementary figure 4 is not referenced in the text.
Referee #2:
iASPP is an inhibitory member of the ASPP proteins known to bind all p53 family members. Chikh et al. now report that iASPP is transcriptionally regulated by p63 in keratinocytes. In parallel iASPP knockdown causes reduced p63 protein levels without affecting mRNA expression.
The present findings are novel and conceptually interesting, however a number of fundamental questions needs to be address in order to make this work stronger.
A crucial point that needs clarification is to determine whether iASPP knockdown affects p63 protein translation or stability. Is this effect proteasome-dependent? It is conceivable that iASPP binding to p63 may favor stabilization of the p63 protein. It has been recently shown that IRF6 controls p63 protein levels in differentiating keratinocytes through a proteasome-dependent mechanism (Moretti et al, JCI 2010) . Are these mechanisms related?
iASPP knockdown causes downregulation of two microRNA, miR-574 and miR-720. What is the mechanism? Are miR-574 and miR-720 transcriptionally regulated by p63 or by any other iASPP binding partners?
Interestingly, anti-miRNA for either miR-574 or miR-720 are sufficient to rescue p63 expression in differentiated keratinocytes. Are they express in epidermis? Is their expression confined to the suprabasal compartment as one would expect?
iASPP KD keratinocytes are less dense, consistent with either a proliferation defect or with increase apoptosis. iASPP protects cells from apoptosis. Is apoptosis or anoikis increased?
The phenotype obtained by iASPP KD in organotypic cultures is puzzling. How can the epidermis be thicker than wild-type or even form, if cell proliferation is arrested and basal layer markers are completely absent?
Other comments:
In spite of what stated in the text it appears that iASPP does not co-localize in the nucleus with p63, rather its expression is cytoplasmic in all layers of the epidermis. In contrast in human epidermis iASPP and p63 co-localize in the nucleus. What is the functional significance of this difference? The mouse data are confusing and of poor quality. Higher resolution is required in Fig.1a .
How were the p63 binding sites identified in the iASPP promoter? Only isolated hemisites are indicated and the other hemisite is lacking in at least two shown sequences. ChIP-seq data in human keratinocytes (Kouwenhoven EN, PLoS Gen. 2010) indicate that p63 binds in the iASPP genomic locus in different locations of the one reported in this study. Have the author checked the strength of their binding site compared to these ChIP-seq data?
While adhesion is a process controlled by p63 in keratinocytes (Carroll et al. NCB 2006) , there doesn't seem to be much overlap between p63 and iASPP affected genes. Can the author comment on this discrepancy?
Is cell adhesion affected in the organotypic culture?
Minor points: Table S1 : what is the ratio?
Referee #3:
In their manuscript Chikh and colleagues suggest that the p53 inhibitor iASPP exerts its function in skin by positively regulating p63, an essential and one of the most important transcriptional regulator for the formation of stratified epithelia. Chikh et al propose that the mechanistic link between iASPP and p63 are two miRNAs targeting p63. Expression of iASPP represses these miRNAs leading to the stabilization of the p63 protein. The precise functional role of p63 in developing and adult skin remains controversial and the identification of novel mechanisms regulating p63 is greatly important for our basic understanding of how stratified epithelia are formed and maintained. Thus, the identification of miRNA-574 and miRNA-720 as p63 regulators is potentially highly interesting. Unfortunately, the authors fail to provide any evidence that these miRNAs are functionally important for keratinocytes in vitro or in vivo. Furthermore no evidence or potential mechanism is provided connecting iASPP with expression of these miRNAs. In sum, the authors have not convincingly demonstrated that iASPP and p63 act in an auto-regulatory feedback loop, as stated in the title, and I cannot recommend the manuscript for publication in EMBO J in its present form.
1.
A better validation and more controls are needed to determine iASPP as a transcriptional target of p63. At a minimum the authors need to provide a negative control in their ChIP experiment (ie a non-targeted promoter region) or provide promoter luciferase assays to confirm their findings.
2.
siRNA experiments need confirmation by rescue experiments to exclude off-target effects. 3.
The authors find that over-expression of iASPP leads to increased expression of p63, which could also be explained via indirect mechanisms and might be due to the negative regulation of p53 in these cells. Did the authors consider this possibility? 4.
Instead the authors suggest that iASPP stabilizes p63 by down-regulating two specific miRNAs and convincingly demonstrate that miR-574-3p and miR720 target p63. However, no further evidence is provided that these miRNAs contribute to keratinocyte proliferation or differentiation. If these miRNAs are indeed the major link between iASPP and p63 in keratinocytes, knock-down of them in Sh-iASPP cells should, for example, rescue the phenotype the authors describe in figure 4.
5.
Similarly, although the authors show in figure 3G that anti miR-720 and 574-3p can be used to rescue p63 levels in high calcium, they do not provide evidence for a functional role of these miRNAs in keratinocytes by testing these transduced keratinocytes for their ability to proliferate, differentiate and re-constitute skin. 6.
Along the same line, the authors do not provide any mechanism of how iASPP negatively controls expression of these miRNAs.
7.
The results shown in the re-constitution assay in figure 6 are confusing and the quality of the labeling needs to be improved. In the provided figures, neither p63 nor iASPP staining appears to be nuclear. There is also no convincing Ki67 staining and control epidermis does not seem to express K1. In addition, knock-down of p63 and iASPP should result in reduced proliferation which was measured by Ki67. However, the epidermis seems to be much thicker than controls. Where are these cells in Sh-iASPP re-constituted epidermis come from? One could argue that the increase in layers in the absence of proliferation is due to decreased terminal differentiation but the authors also show that K1 and Ivl is increased, indicating enhanced differentiation.
8.
It is also unclear to me why the authors do not validate any of their indentified factors (Fig.  4B ) in the in vitro reconstitution assay in figure 5.
Minor comments: 1.
The IF staining of iASPP in mouse skin in figure 1 A does not look nuclear and thus little co-localisation can be seen Answer to Referees:
Referee #1
In their manuscript, Chikh et al investigate a role for iASPP in skin. They show expression of iASPP in the developing mouse skin and in human skin tissue and in culture, and demonstrate that iASPP levels inversely correlate with the normal differentiation program. They identify a direct connection between iASPP and p63, with direct binding of p63 to the iASPP promoter. Functionally, they show increased iASPP expression with increased p63 expression and decreased iASPP expression with p63 knockdown. Conversely, they similarly demonstrate that manipulation of iASPP positively effects the expression of p63. Interestingly this effect of iASPP manipulation on p63 is only seen at the protein level, but not at the p63 RNA level. They subsequently use microRNA profiling to identify 2 microRNAs that are increased following iASPP knockdown, and functionally show that manipulation of the expression of these microRNAs affects p63 expression. Microarray analysis is used to link iASPP knockdown with regulation of cell adhesion and desmosomal proteins, and characterization of the cells with iASPP-knockdown is performed. Finally, the effect of iASPP on skin regeneration in a 3D organotypic model identifies that loss of iASPP promotes accelerated differentiation in keratinocytes.
Overall, the manuscript is well written and presents a number of important and interesting findings linking iASPP to both skin biology, p63 function and differentiation. In most cases, the data is well presented, with adequate controls. However, overall, the emphasis of the results is a little misplaced, and as such, the main discussion points could be strengthened. 
Reply

1.
Reply 1. We agree with this reviewer and thank him/her for the useful criticism. We have now changed the title of the manuscript into "IASPP/p63 auto-regulatory feedback loop is required for the homeostasis of stratified epithelia".
2.
The section of the introduction dealing with skin differentiation (paragraph 1) needs more references to adequately describe the normal differentiation process and the contribution of cell adhesion.
Reply 2. We agree that the section of the introduction describing the normal differentiation process and the contribution of cell adhesion was indeed without adequate references. We have now updated this section by rephrasing it and also by filling it with appropriate references.
3.
In figure 1 , the data clearly shows a role for iASPP expression in human keratinocytes (immunostaining on sections and matching protein level changes with calcium induced differentiation in culture). However, the staining in mouse and human tissues does not appear similar in all cases. It seems more diffuse and suprabasal in the mouse tissue, described as being in both the cytoplasm and in the nucleus. However, in the human skin, it appears only nuclear. In the human cultures, iASPP levels decrease with differentiation, whereas in the upper layers of the mouse tissue (E15.5, P1), expression seems to persist. Perhaps some clearer higher-powered images on the mouse sections would help. Is the antibody known to have similar specificity for mouse and human? The differences could be discussed more.
Reply 3. We appreciate the reviewers acknowledgement that the data in Figure 1 clearly shows a role for iASPP expression in human keratinocytes, which we intended as the main message from the figure. We also agree with the reviewer that the staining presented in images included in Figure 1A were 
4.
From figure 2 and supp. figure 1, expression of the TAp63 isoforms appears to induce iASPP expression the most, but is not commented on. Does this reflect a response to TA inducing senescence or apoptosis, or an induction of differentiation? Are all isoforms of p63 (or at least the TA and ∆N groups) lost with iASPP knockdown?
Reply 4. We agree with the reviewer that a clarification of the involvement of TAp63 point was needed in the previous version of the manuscript.
We have now included more evidence suggesting that iASPP could modulate both TA and ΔNp63. The CHIP experiment (in figure 2A) figure 2F ). Therefore, we believe that the auto-regulatory feedback loop between iASPP and p63 is actually involving both TA and ΔNp63.
5.
In figure 3D , were any other microRNAs examined that were not induced by sh-iASPP? These could be included as negative controls. In figure 3E , was repression of p63 luciferase more potent in cells that do not express endogenous p63? Was this only repression of ∆Np63? In Figure  3F , what was the efficiency of the antagomirs? Is it known how knockdown of iASPP induces miRNA expression? 
Reply 5. As suggested by the referee, we have now included miR-193a-3p, one of the microRNAs that were not affected by sh-IASPP, as a negative control. This is incorporated into the updated version of figure 3 (specifically in 3E and 3F).
The question of whether repression of p63 luciferase is more potent in cells that do not express endogenous p63 is a very relevant. Unfortunately, we realize that the old figure 3E (now 3G in the update version) was inadvertently mislabeled from a previous version of the manuscript and the data shown was in fact generated in HEK293 cells (p63null cells). Previous experiments performed
6.
The emphasis on figure 4A and 4B is a little strong, taking into account the subsequently described cellular phenotypes. For such a dramatic loss of p63, PERP and desmosomal proteins, a significant decrease in cell number or attachment would be expected, considering previous studies (e.g. Ihrie et al, 2005; Carroll et al, 2006) . This could be discussed more. Does the cellular phenotype in figure 4C look similar to calcium-induced differentiation in these conditions? While in figure 5B , the premature differentiation is quite impressive. Could also be discussed more. Kurata et al., 2004 (JBC, 2004 
Reply 6. According to our results shown in figures 4 A-B silencing of iASPP is affecting the integrity
7.
In figure 4 or 5, would over-expression of iASPP affect the normal differentiation process? In the cells with expression of the anti-miR-720 or 574-3p antagomirs with calcium ( fig. 3g) (Bergamaschi et al., 2006; Liu et al., 2009; Liu et al., 2008) . However, these data are consistent with a previous report where siRNA-iASPP in non-transformed cells (lymphocytes and fibroblasts) similarly reduced apoptosis (Laska et al., 2007) . We are happy to provide the data generated with Sh-iASPP cells in HaCaT and N-TERT cells. However, we strongly believe these data do not strengthen the message of our manuscript, which is more focused on the effect of iASPP/p63 axis in fine-tuning the homeostatic balance in the epidermis. This is an area of ongoing research in our group.
9.
It would be interesting to see the effect of iASPP knockdown on stem cells e.g. FACS analysis or culture of colonies on feeders. figure S3D) Minor comments 1.
Reply 9. As we mention in figure 1B iASPP is expressed within the bulge of mouse hair follicles and that suggests a possible involvement in 'stemness'. We believe that this is an important issue and is also an area of ongoing research in our group, but is beyond the scope of the current manuscript. We have performed a colony formation assay comparing the amount and the sizes of colonies between keratinocytes silenced for iASPP versus the control cells (Supplementary
Similarly, for RT-PCR, p63 bands should be labeled with the correct isoform or DBD. 4. Fig 1B needs labels on the y-axis e.g. relative cDNA levels.
5.
Supplementary figure 4 is not referenced in the text. 
Reply Minor comments
Reply 1. We agree that clarification of whether iASPP knockdown affects p63 protein translation or stability is needed. In new figure 3C we show that blocking the proteasome degradation pathway with MG132 in iASPP knockdown cells is not sufficient to restore p63 protein level. These new data therefore exclude the possibility that the reduced expression of p63 induced by silencing of iASPP is a result of increased proteasomal degradation. This further strengthens the role of the 2 novel microRNAs that, in the absence of iASPP, reduce p63 protein expression by inhibiting its translation in a different manner to the interaction recently described between IRF6 with ΔNp63. Also, IRF6 expression seems to increase during differentiation while iASPP expression (as ΔNp63) is reduced. We have not identified any link between iASPP and IRF6 (as shown in new figure 2F) although we cannot rule out the possibility that IRF6 is upstream of iASPP and therefore unaffected by the proposed regulatory feedback loop between iASPP and p63. From the mechanisms described it appears that IRF6 and iASPP have an opposite contribution in regulating the p63-dependent differentiation process.
2. iASPP knockdown causes downregulation of two microRNA, miR-574 and miR-720. What is the mechanism? Are miR-574 and miR-720 transcriptionally regulated by p63 or by any other iASPP binding partners?
3. Interestingly, anti-miRNA for either miR-574 or miR-720 are sufficient to rescue p63 expression in differentiated keratinocytes. Are they express in epidermis? Is their expression confined to the suprabasal compartment as one would expect?
Reply 2 & 3. As shown in figure 3, iASPP knockdown de-represses and therefore up-regulates miR-574-3p and miR-720. As yet, we cannot provide a detailed molecular mechanism to explain this and -as indicated in our response comment 5 by reviewer 1 -we consider that this is beyond the scope of the current manuscript. However, we can exclude any significant transcriptional regulation of miR-574-3p and miR-720 by TA and Δnp63 and as well p53 and we can speculate as to possible mechanisms based upon their physiological localization in normal skin. New in situ hybridization experiments (shown in new figure 7A) demonstrate that miR-574-3p and miR-720 are localized to the upper layers of the epidermis where iASPP expression is reduced or absent. This indicates that they are not required in the proliferative compartment where the iASPP/p63 axis might control the integrity of the differentiation program, but they can be de-repressed in the upper layers of the epidermis.
4. iASPP KD keratinocytes are less dense, consistent with either a proliferation defect or with increase apoptosis. iASPP protects cells from apoptosis. Is apoptosis or anoikis increased? (Frye et al., 2003; Waikel et al., 2001; Yang and McKeon, 2000) .
Reply 4. We believe that this effect on cell density is mainly due to the slowdown in proliferation that we have detailed by the BrdU kinetic experiments in fig. 4E in which we showed that silencing of iASPP reduces the speed of the transition through all phases of the cell cycle. Specific experiments were also performed on 2 keratinocyte cell lines (HaCaT and N-TERT) exposed to different DNA damaging agents (such as Staurosporin and UVB radiation). Assessment of annexin V staining at 24 h using flow cytometry showed increased apoptosis in control cultures
Reply 5. The phenotype of the organotypic cultures is linked to the previous point and we believe is one of the main messages of this study. Silencing iASPP is certainly affecting the proliferative compartment of the epidermis. iASPP is predominantly expressed in the basal layer where its removal could reduce the stem cell population. Such an effect is well documented as often being counterbalanced by an increased number of transient amplifying cells (TACs). These cells move upwards to the spinous and granular layers and committed to differentiation
Deregulation of the basal proliferative compartment of the epidermis (via inhibition of iASPP-p63 axis) results in an accelerated differentiation program, which could lead ultimately to an increase in stratification of the epidermis. We believe that we have clearly shown this in the updated version of the manuscript; iASPP silencing is reducing the number of cells in the basal layer of the epidermis (confirmed by the expression pattern of basal proliferation markers in new figure 6) and this is counterbalanced by an increased amount of stratified suprabasal layers (as shown by the differentiation markers in new figure 6), which ultimately gives rise to a thicker epidermis.
Finally, we should point out that our manuscript was originally part of a back-to-back submission with a manuscript from another group who had analysed the epidermis of wild type and of iASPP knockout mice. They demonstrate that loss of iASPP expression causes profound morphological abnormalities in the mice epidermal structure. Importantly, in comparison to wild type skin sections, iASPP silenced mouse epidermis is noticeably thicker and this is associated with an increase in the number of cells predominantly located in the spinous and granular layers.
Other comments: a) In spite of what stated in the text it appears that iASPP does not co-localize in the nucleus with p63, rather its expression is cytoplasmic in all layers of the epidermis. In contrast in human epidermis iASPP and p63 co-localize in the nucleus. What is the functional significance of this difference? The mouse data are confusing and of poor quality. Higher resolution is required in Fig.1a . Figure 1A were not entirely clear. Kurata et al., 2004 (JBC, 2004 
Reply a) We agree with the reviewer that the staining presented in images included in
showed suppression of α 3 Integrin in human primary keratinocytes by p63 knockdown and by differentiation. Our data instead showed upregulation of α 3 Integrin in the absence of iASPP (and consequent loss of p63). As a reflection in our system differentiation is not inhibited but actually promoted.
We have also performed adhesion assays on collagen, fibronectin or matrigel (data not shown) without detecting significant differences between cells depleted for iASPP versus sh-control. Keratinocytes silenced for iASPP are flattened and adherent resembling the calcium-induced differentiation phenotype and we believe that deregulation of genes observed in cell adhesion complexes is associated or could be simply the consequence of this peculiar phenotype. As a matter of fact proteins involved in cell adhesion are modulated during the differentiation process. At this regard Seo et al, (Genomics,2005) , performed an elegant study where they classified genes affected by calcium treatment in keratinocytes using the SOURCE database of Stanford genes. In the category 'cytoskeleton and cell adhesion', Desmoplakin was up-regulated while β1Integrin was among the genes down-regulated. Our data is in line with this result. Overall, our observations reveal that cells depleted for iASPP display some of the features of terminal differentiation. d) Is cell adhesion affected in the organotypic culture? Green KJ lab (JBC, 2009) Minor points: Table S1 : what is the ratio? Reply: The term ratio in Table S1 refers to the number of genes modulated by PPP1R13L silencing belonging to a particular biological process over the total number of genes involved in that process
Reply d) New supplementary figure S4 shows how silencing miR-574-3p and miR-720 by specific antagomirs is sufficient to restore the expression patterns of few desmosomal proteins (Desmocollin 3, Desmoplakin and Desmoglein 1) in iASPP-depleted skin reconstructs. Therefore the desmosomal integrity complex is affected in iASPP silenced organotypic cultures (confirming the monolayers data). Recently an elegant study from
Referee #3
Reply. We thank this reviewer for acknowledging that identification of miR-574-3p and miR-720 as p63 regulators is potentially highly interesting. We have followed his/her constructive advices and generated more experiments which have been incorporated in the revised version of the manuscript. We anticipate that these ensure that we have fully addressed all of his/her comments, as we detail point-by-point below.
1.
A better validation and more controls are needed to determine iASPP as a transcriptional target of p63. At a minimum the authors need to provide a negative control in their ChIP experiment (i.e. a non-targeted promoter region) or provide promoter luciferase assays to confirm their findings. figure 2A) . This promoter does not contain any p53/p63 consensus site and indeed p63 is not recruited to this promoter. As a positive control we also performed ChIP experiment using p21.
Reply 1. We agree and we do apologize for having omitted to include a negative control in the previous version of the figure. However we have now repeated the CHIP experiment by including as a negative control the thymidine kinase (TK) promoter (new
2.
siRNA experiments need confirmation by rescue experiments to exclude off-target effects. figure 4H ) and for the organotypic cultures with the antagomirs for 6, and Supplementary figures S4) .
3.
The authors find that over-expression of iASPP leads to increased expression of p63, which could also be explained via indirect mechanisms and might be due to the negative regulation of p53 in these cells. Did the authors consider this possibility? Instead the authors suggest that iASPP stabilizes p63 by down-regulating two specific miRNAs and convincingly demonstrate that miR-574-3p and miR720 target p63. However, no further evidence is provided that these miRNAs contribute to keratinocyte proliferation or differentiation. If these miRNAs are indeed the major link between iASPP and p63 in keratinocytes, knock-down of them in Sh-iASPP cells should, for example, rescue the phenotype the authors describe in figure 4.
5.
Similarly, although the authors show in figure 3G that anti miR-720 and 574-3p can be used to rescue p63 levels in high calcium, they do not provide evidence for a functional role of these miRNAs in keratinocytes by testing these transduced keratinocytes for their ability to proliferate, differentiate and re-constitute skin. 
6.
Reply 6. As we have indicated in our responses to reviewer 1 (comment 5) and reviewer 2 (comment 2), we cannot yet provide a detailed molecular mechanism by which iASPP repress the expression of these miRNAs. We agree that this is important and it is an area of ongoing research in our laboratory, but we consider it to be beyond the scope of the current manuscript. However we have at least excluded a p53 involvement in this feedback loop.
7.
Reply 7. We thank this reviewer for having identified that neither p63 nor iASPP staining appears to be clearly nuclear in figure 5A . As we have indicated in our responses to reviewers 1 and 2 on the same issue, the inconsistencies were primarily technical and related to the timing of sectioning and performance of immunohistochemistry. We have now reanalyzed our samples and improved the image quality to update Figure 1A and (Frye et al., 2003; Waikel et al., 2001; Yang and McKeon, 2000 Figure 4H ) the rescue of PERP by inducing specific anti-miR-574-3p and anti-miR-720.
The IF staining of iASPP in mouse skin in figure 1 A does not look nuclear and thus little co-localisation can be seen Reply 1. As indicated in our response to comment 7 above, inconsistencies were primarily technical and related to the timing of sectioning and performance of immunohistochemistry. We have now reanalyzed our samples and improved the image quality to update Figure 1A and demonstrate more clearly how iASPP co-localize with p63 in the nuclei in the basal layer during skin development. Dear Dr. Bergamaschi, Your revised manuscript has now been re-assessed by original referees whose comments you will find enclosed. These scientist emphasize that the science is sound and appropriate now, but minor clarifications and some changes to presentation might help the overall comprehension. Please provide us with an ultimate version that should also include an author contribution and conflict of interest statement after the acknowledgements to enable formal acceptance of the study.
Yours sincerely,
Editor
The EMBO Journal REFEREE REPORT Referee #2:
In the present version of the manuscript the authors have appropriately responded to most of the referee's comments. Although some relevant questions remain unsolved, this work provides a significant advancement toward the understanding of iASPP function in the epidermis. Additional comments:
Cell cycle progression is inhibited in sh-iASPP keratinocytes, in parallel with downregulation of Cyclin D2 and p21. Downregulation of p21 is surprising, because sh-p63 actually induces p21 in human and mouse keratinocytes (see for instance Truong et al. G&D 2006 G&D , Nguyen et al. G&D 2006 . If the cell cycle is blocked, p21 should be upregulated, unless low levels of p21 are just a mere long-term consequence of cell cycle arrest. This point should be appropriately discussed. Were other cell cycle regulators measured to demonstrate the specificity of this observations?
The authors state that cyclin D2 is a p63 target gene. A reference should be provided.
In Table S2 , the clone distribution is measured at day 10, with a convincing difference in large clones between control and iASPP shRNA. However, the definition of holoclones goes beyond the ability to make large clones after only 10 days in culture (see Barrandon and Green 1987) . Appropriate nomenclature should be used.
The following statement should be corrected: " The stratified epithelia were strongly positive for K1 whose expression corresponds to the granular layer..". Correct to: spinous layer.
In their revised version of the manuscript Chikh and colleagues addressed all my major concerns and the authors immensely improved the overall quality with the additional experiments. The manuscript now convincingly shows that iASPP regulates p63 via two novel micro RNAs and that this interaction is important for keratinocyte proliferation and differentiation.
Before publication I would strongly encourage the author to re-write the abstract. In its current form it is very vague and does not name the actual functions of iASPP. For instance, the sentence ...'these data reveal iASPP as a key regulator of epithelial homeostasis' does not reveal whether it promotes or inhibits adhesion, proliferation and differentiation.
The IF of iASPP in figure 1 is more convincing than the IHC. Since both stainings are supposed to show the same, the authors might want to consider removing the IHC from figure 1. Answer to Referees:
Referee #2
In the present version of the manuscript the authors have appropriately responded to most of the referee's comments. Although some relevant questions remain unsolved, this work provides a significant advancement toward the understanding of iASPP function in the epidermis.
Additional comments:
1) Cell cycle progression is inhibited in sh-iASPP keratinocytes, in parallel with downregulation of Cyclin D2 and p21. Downregulation of p21 is surprising, because sh-p63 actually induces p21 in human and mouse keratinocytes (see for instance Truong et al. G&D 2006 G&D , Nguyen et al. G&D 2006 . If the cell cycle is blocked, p21 should be upregulated, unless low levels of p21 are just a mere long-term consequence of cell cycle arrest. This point should be appropriately discussed. Were other cell cycle regulators measured to demonstrate the specificity of this observation? 
